All Picks
Every pick with full AI analysis, catalyst research, and actionable signals.
Active Positions (Paper)
Pick Archive
Eli Lilly's Weight Loss Empire Just Crushed Earnings - This Bull Run Has Legs
Eli Lilly just crushed Q4 earnings with its GLP-1 weight loss drugs Mounjaro and Zepbound posting triple-digit growth, and with management projecting another 25% revenue surge in 2026, this pharma giant's obesity treatment dominance is just getting started.
GE Aerospace Is Finally Taking Off - Time to Board This Rocket
After years of turbulence, GE Aerospace has finally broken free from its corporate baggage and is soaring on the back of knockout earnings and red-hot aerospace demand that has this former industrial dinosaur looking more like a rocket ship with a 75% momentum score.
Veracyte's Genomic Diagnostics Empire Hits Growth Inflection Point
Veracyte's genomic diagnostics business just hit a major growth inflection point with its strongest quarter on record, fresh product launches ahead, and accelerating profitability momentum that could finally break this biotech out of its recent trading range.
TSM: The AI Goldmine Everyone's Sleeping On
While everyone's chasing flashy AI software companies, Taiwan Semiconductor (TSM) is quietly printing money as the picks-and-shovels play behind every major AI chip, trading at a 15% discount despite crushing earnings and guiding for 30% annual growth through 2029.